AzTrials
AzTrials

Mouth DiseasesNCT02357199

Interventional Study Targeting Oral Infections in Patients With Chronic Kidney Disease

A study testing Intensive oral care & didactic training in people with Mouth Diseases and Renal Insufficiency, Chronic, run by University of Copenhagen at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to investigate the prevalence of oral infection in chronic renal disease patients and to examine whether a focused oral hygiene intervention can reduce oral infection leading to reduced systemic inflammatory parameters in chronic renal disease patients in hemodialysis, chronic renal disease patients… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Mouth Diseases, Renal Insufficiency, Chronic
What is being tested?
Intensive oral care & didactic training
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
93 participants
Where
1 siteDenmark
Study dates
Jan 2015to Aug 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients on a kidney transplant waiting list or patients who have had a kidney transplant (1-1½ year previously)
  • Dentate patients (>10 teeth)
  • Age >18 years
  • Danish language

Who cannot join

  • Patients not capable of following the research protocol
  • Legally unavailable
  • Need of antibiotic prophylaxis with dental treatment
  • Heart valve surgery

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Department of Odontology, Faculty of Health Sciences, University of Copenhagen

    Copenhagen, DK-2200

Other trials in Denmark

About this study

This study aims to investigate the prevalence of oral infection in chronic renal disease patients and to examine whether a focused oral hygiene intervention can reduce oral infection leading to reduced systemic inflammatory parameters in chronic renal disease patients in hemodialysis, chronic renal disease patients waiting for kidney transplantation, and chronic renal disease patients who has been transplanted 1-1½ year previously. The results will be compared to a gender- and age-matched healthy control group.

Read the detailed description

Aim:

The aim is to examine if a focused oral care procedure to reduce oral infection will be mirrored in reduction of systemic inflammatory parameters in chronic renal disease patients.

Specific research questions:

Can oral infection and systemic inflammatory parameters in chronic renal disease patients be reduced by 1 month of professional oral care and individual prophylactic instruction and can a potential reduction of inflammation be continuously achieved at a 3 months follow-up.

Study design:

Randomized, double-blinded (investigator, outcomes assessor), controlled study. For Eligibility Criteria and Outcome Measures, please see elsewhere in the ClinicalTrials.gov Protocol Registration System.

Participants:

A: Hemodialysis patients, inclusion n=34, B: Hemodialysis patients on a kidney transplant waiting list, inclusion n=34, C: Patients who have had a kidney transplant (1-1½ years after transplantation), inclusion n=34. D: Gender- and age-matched healthy control group.

Number of included patients is estimated from a hypothesis-generating pilot study, a statistical power analysis and the estimated loss to follow-up based on experience from previous research projects in the Nephrology Department.

Intervention and control:

The intervention consists of professional oral care (addressing periodontal and oral mucosal infections, salivary gland dysfunction and caries prevention) and a didactic approach to individual instruction in oral hygiene/prophylactic measures performed by a dental hygienist at three visits: baseline, 2 weeks after baseline and 1 month after baseline.

The research data will be registered by a blinded investigator before the first visit at the dental hygienist and after 3 months.

The control group will follow best-clinical-practice procedures currently implemented in the hospital.

Being tested
Intensive oral care & didactic training
Keywords
Mouth Diseases, Renal Insufficiency, Chronic, Intervention Studies
Medical subject headings
Mouth Diseases, Renal Insufficiency, Chronic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intensive oral care & didactic trainingOther

    Professional (dental hygienist) intensive oral care intervention and individual patient training/didactic instruction to promote patient compliance and patient capability of oral preventive measures in a long-term perspective.

Study groups in NCT02357199
Study groupRoleWhat they receive
Intensive oral care & didactic trainingExperimentalProfessional (dental hygienist) intensive oral care intervention and individual patient training/didactic instruction to promote patient compliance and patient capability of oral preventive measures in a long-term perspective.
Receives: Other: Intensive oral care & didactic training
Standard oral careNo interventionStandard oral care protocol consisting of referral by staff in the Department of Nephrology to general dental practitioner followed by patient self-administration of tooth brushing, fluoride toothpaste and oral lubricants.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gingival inflammation

    Gingival inflammation measured by gingivitis index

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  2. C-reactive protein, plasma

    Blood sample

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

Secondary outcomes (30)
  1. Dental bacterial plaque

    Measured by plaque index

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  2. Periodontal disease

    Measurement of attachment level

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  3. Whole saliva flow rate, unstimulated

    Sialometry

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  4. Whole saliva flow rate, stimulated

    Sialometry

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  5. Saliva composition: Sodium

    Sialochemistry

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  6. Saliva composition: Chloride

    Sialochemistry

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  7. Saliva composition: Potassium

    Sialochemistry

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  8. Saliva composition: Total calcium

    Sialochemistry

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  9. Saliva composition: Inorganic phosphate

    Sialochemistry

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  10. Saliva composition: Total protein

    Sialochemistry

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  11. Saliva composition: Albumin

    Sialochemistry

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  12. Saliva composition: Amylase activity

    Sialochemistry

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  13. Saliva composition: Secretory IgA

    Sialochemistry

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  14. Oral candidiasis

    Smear test

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  15. Hematologic status: Erythrocytes

    Blood sample

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  16. Hematologic status: Hemoglobin

    Blood sample

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  17. Hematologic status: Leukocytes

    Blood sample

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  18. Hematologic status: Thrombocytes

    Blood sample

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  19. Hematologic status: Transferrin

    Blood sample

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  20. Hematologic status: Iron

    Blood sample

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  21. Calcium metabolism

    Blood sample

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  22. Phosphate metabolism

    Blood sample

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  23. Renal function: Carbamide

    Blood sample

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  24. Renal function: Bicarbonate

    Blood sample

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  25. Renal function: Creatinine

    Blood sample

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  26. Renal function: Albumin

    Blood sample

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  27. Renal function: Potassium

    Blood sample

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  28. Renal function: Sodium

    Blood sample

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  29. Oral Health Impact Profile

    Quality of life questionnaire

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

  30. Medical Outcomes Study Short Version

    Quality of life questionnaire

    Measured: Change from baseline examination (before oral care intervention) at 3-months follow-up examination

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2015 (estimated)
  2. Study startJan 2015
  3. Primary completionAug 2015
  4. Study completionAug 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
93 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02357199
Sponsor's protocol ID
102-2084/14-3000
Status last verified
Aug 2015
First submitted
28 Jan 2015
Last updated
31 Aug 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008 Sep;3(5):1526-33. doi: 10.2215/CJN.00950208. Epub 2008 Aug 13.

    PubMed 18701615
  • McIntyre C, Harper I, Macdougall IC, Raine AE, Williams A, Baker LR. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients. Clin Nephrol. 1997 Dec;48(6):371-4.

    PubMed 9438096
  • Thorman R. Oral health in patients with chronic kidney disease. Stockholm, Sweden: Karolinska Institutet; 2009

Questions about this trial

What is this clinical trial studying?

A study testing Intensive oral care & didactic training in people with Mouth Diseases and Renal Insufficiency, Chronic, run by University of Copenhagen at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Aug 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gingival inflammation (time frame: Change from baseline examination (before oral care intervention) at 3-months follow-up examination). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02357199, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2015; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in